Highlights and Quick Summary
- Shareholders Equity (Total) for the quarter ending September 30, 2022 was $96.3 Million (a -16.45% decrease compared to previous quarter)
- Year-over-year quarterly Shareholders Equity (Total) decreased by -37.87%
- Annual Shareholders Equity (Total) for 2021 was $155 Million (a -35.99% decrease from previous year)
- Annual Shareholders Equity (Total) for 2020 was $242 Million (a 29.48% increase from previous year)
- Annual Shareholders Equity (Total) for 2019 was $187 Million (a -300.95% decrease from previous year)
Visit stockrow.com/BCEL
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Shareholders Equity (Total) of Atreca, Inc.
Most recent Shareholders Equity (Total)of BCEL including historical data for past 10 years.Interactive Chart of Shareholders Equity (Total) of Atreca, Inc.
Atreca, Inc. Shareholders Equity (Total) for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | $96.25 | $115.2 | $137.78 | – |
| 2021 | $154.93 | $175.43 | $198.6 | $221.4 | $154.93 |
| 2020 | $242.06 | $261.28 | $154.12 | $170.14 | $242.06 |
| 2019 | $186.95 | $205.0 | $218.88 | $0.0 | $186.95 |
| 2018 | – | $-93.03 | $0.0 | $0.0 | $-93.03 |
| 2017 | – | – | – | – | $-56.57 |
Business Profile of Atreca, Inc.
Sector: Healthcare
Industry: Biotechnology